Produktname:2-(4-(Dibenzo[b,d]thiophen-4-yl)phenyl)dibenzo[f,h]quinoxaline
IUPAC Name:2-(4-{8-thiatricyclo[7.4.0.0²,⁷]trideca-1(13),2,4,6,9,11-hexaen-6-yl}phenyl)-1,4-diazatriphenylene
- CAS:1332748-56-7
- Molekulare Formel:C34H20N2S
- Reinheit:95%
- Katalognummer:CM221243
- Molekulargewicht:488.61
Packungseinheit |
Verfügbarer Vorrat |
Preis($) |
Menge |
Nur für den Einsatz in Forschung und Entwicklung..
Produkt-Details
- CAS-Nr.:1332748-56-7
- Molekulare Formel:C34H20N2S
- Schmelzpunkt:-
- SMILES-Code:C1(C2=CC=C(C3=C4C(C5=CC=CC=C5S4)=CC=C3)C=C2)=NC6=C(C=CC=C7)C7=C(C=CC=C8)C8=C6N=C1
- Dichte:
- Katalognummer:CM221243
- Molekulargewicht:488.61
- Siedepunkt:
- Mdl-Nr.:
- Lagerung:
Category Infos
- Quinoxalines
- Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.